SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZUCCHINI, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.380
AS - Asia 2.763
EU - Europa 2.726
SA - Sud America 392
AF - Africa 52
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.248
SG - Singapore 1.112
CN - Cina 884
PL - Polonia 676
RU - Federazione Russa 411
DE - Germania 405
BR - Brasile 330
UA - Ucraina 287
IT - Italia 275
GB - Regno Unito 228
HK - Hong Kong 226
TR - Turchia 190
FI - Finlandia 182
VN - Vietnam 141
CA - Canada 75
FR - Francia 59
SE - Svezia 52
IN - India 50
MX - Messico 43
ID - Indonesia 35
JP - Giappone 33
ES - Italia 29
AR - Argentina 27
AT - Austria 27
ZA - Sudafrica 27
CZ - Repubblica Ceca 26
BD - Bangladesh 22
LT - Lituania 18
NL - Olanda 18
IQ - Iraq 14
BE - Belgio 12
EC - Ecuador 10
IR - Iran 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
MA - Marocco 6
PK - Pakistan 6
VE - Venezuela 6
CL - Cile 5
EG - Egitto 5
PT - Portogallo 5
SA - Arabia Saudita 5
DO - Repubblica Dominicana 4
JO - Giordania 4
UZ - Uzbekistan 4
AU - Australia 3
DZ - Algeria 3
KE - Kenya 3
KR - Corea 3
LB - Libano 3
PY - Paraguay 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
NP - Nepal 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
SN - Senegal 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
GE - Georgia 1
GN - Guinea 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
QA - Qatar 1
SR - Suriname 1
Totale 12.318
Salva come PNG Salva come JPEG
Città #
Ashburn 776
Fairfield 683
Warsaw 666
Singapore 651
Woodbridge 645
Houston 394
Beijing 354
Chandler 343
Jacksonville 313
Santa Clara 275
Seattle 263
Ann Arbor 256
Wilmington 243
Hong Kong 226
Munich 204
Cambridge 198
Los Angeles 134
New York 122
Ferrara 112
Nanjing 106
Izmir 102
Helsinki 87
Dallas 75
Princeton 71
San Diego 56
Shanghai 55
Ho Chi Minh City 52
Milan 52
Boardman 38
São Paulo 35
Washington 35
Brooklyn 32
Tokyo 32
Hanoi 31
Turku 31
Buffalo 28
Jakarta 28
London 27
Orem 27
Denver 26
Chennai 25
Montreal 25
Nanchang 25
Phoenix 25
Boston 23
Chicago 23
Mexico City 23
Hebei 21
Johannesburg 20
Poplar 20
Toronto 20
Moscow 19
Stockholm 19
Vienna 19
Falkenstein 18
Frankfurt am Main 18
Bologna 17
Brno 17
Jiaxing 17
San Francisco 17
Norwalk 16
Shenyang 16
The Dalles 16
Atlanta 15
Auburn Hills 14
Hefei 14
Dearborn 13
Falls Church 13
Mcallen 13
Ankara 12
Montréal 12
Tianjin 12
Amsterdam 11
Brussels 11
Manchester 11
Mountain View 11
Rio de Janeiro 11
Bremen 10
Changsha 10
Columbus 9
Ningbo 9
San Mateo 9
Dong Ket 8
Guangzhou 8
Guarulhos 8
Nuremberg 8
Redwood City 8
Roubaix 8
Wroclaw 8
Ardabil 7
Brasília 7
Da Nang 7
Jinan 7
Kunming 7
Mumbai 7
Olomouc 7
Zhengzhou 7
Belo Horizonte 6
Charlotte 6
Council Bluffs 6
Totale 8.693
Salva come PNG Salva come JPEG
Nome #
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats 523
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies? 376
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 349
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes 349
Bystander effect on brain tissue of mesoangioblasts producing neurotrophins 337
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 275
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 234
FGF-2 Overexpression Increases Excitability and Seizure Susceptibility but Decreases Seizure-Induced Cell Loss 226
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 220
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression 210
Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy 209
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 208
Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the Fibroblast Growth Factor-2 system 204
Personalized needles for microinjections in the rodent brain 197
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 191
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 190
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 185
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis 184
Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures 184
A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb 182
Involvement of the neuropeptide orphanin FQ/nociceptin in kainate and kindling seizures and epileptogenesis 181
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis 178
Gene Therapy Tools for Brain Diseases 177
Dendritic targeting of mRNAs for plasticity genes in experimental models of temporal lobe epilepsy 176
Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice 173
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 172
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 169
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 167
Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis? 166
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 164
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice 158
Mechanisms of action of CHF3381 in the forebrain 157
Fibroblast Growth Factor-2 (FGF-2). 156
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 155
Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis 155
Temporal lobe epilepsy model, neural stem cells and gene therapy 154
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy 154
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 153
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats 153
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 151
Implication of sestrin3 in epilepsy and its comorbidities 148
Properties and maturation of adult-generated dopaminergic neurons in the mammalian olfactory bulb 147
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 147
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 146
Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in Escherichia coli, Biochemical Characterization, and Selective Inhibition by 6-(p-n-Octylanilino)Uracil 141
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 139
Dynorphin and Nociceptin/Orphanin FQ (N/OFQ). 134
Different patterns of induction of fibroblast growth factor-2 and brain-derived neurotrophic factor messenger RNAs during kindling epileptogenesis, and development of a herpes simplex vector for fibroblast growth factor-2 gene transfer in vivo 128
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 126
Increased susceptibility to kainate seizures and decreased seizure-induced cell loss in transgenic mice overexpressing fibroblast growth factor-2 123
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 116
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development 109
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease 108
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 107
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 106
Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy 105
Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats 100
The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models 97
null 97
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells 97
Gene therapy of the nervous system by herpes virus vectors 96
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 96
Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study 95
null 94
null 94
null 93
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 92
null 92
null 89
null 89
null 89
Molecular approaches to inhibit HIV-1 tat expression and functions 89
Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders 80
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells 79
Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats during EEG Recordings 73
Possible Approaches of Gene Therapy of AIDS. 72
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology 70
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist 70
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? 68
Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements. 61
null 43
Totale 12.447
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.738
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.455
Totale 55.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021609 0 0 0 0 0 100 43 113 38 157 113 45
2021/2022742 31 94 61 24 27 28 47 42 20 48 69 251
2022/2023734 74 44 48 75 119 101 38 77 100 4 40 14
2023/2024881 41 46 41 12 48 222 89 97 66 62 50 107
2024/20252.055 55 47 152 114 215 264 86 109 324 157 253 279
2025/20263.072 654 194 397 756 830 241 0 0 0 0 0 0
Totale 12.447